Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $18.13M.
ENTERPRISE VALUE (EV)
$18.13M
Invivyd, Inc.
Market Cap
$244.82M
Enterprise Value (EV)
$18.13M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Invivyd, Inc. (IVVD) | $244.82M | $18.13M |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.83M | $234.95M |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.78M | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $243.34M | $367.77M |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $245.72M | $260.37M |
| Q32 Bio Inc. (QTTB)vs › | $246.30M | $145.32M |
| InflaRx N.V. (IFRX)vs › | $240.82M | $74.44M |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.09M | $138.51M |
| Quantum-Si incorporated (QSI)vs › | $249.79M | $229.39M |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $239.10M | $154.34M |
Market Cap
$244.82M
Total Debt
$0.00
Cash
$226.69M
Enterprise Value
$18.13M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
